SUPERNUS PHARMACEUTICALS INC

Ticker: SUPN CUSIP: 868459108 Class: EQTY

Connor, Clark & Lunn Investment Management Ltd.'s Holding History (CIK: 0001596800)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 122,793 Value ($000) $3,870 Avg Close $32.05 Range $29.16 - $34.26
Q1 2025
Shares 172,259 Value ($000) $5,641 Avg Close $35.44 Range $30.37 - $40.28
Q4 2024
Shares 201,569 Value ($000) $7,289 Avg Close $35.21 Range $30.83 - $39.37
Q3 2024
Shares 214,864 Value ($000) $6,699 Avg Close $31.21 Range $25.55 - $35.41
Q2 2024
Shares 87,444 Value ($000) $2,339 Avg Close $28.98 Range $25.53 - $34.49
Q1 2024
Shares 81,326 Value ($000) $2,774 Avg Close $29.77 Range $26.27 - $35.44
Q4 2023
Shares 103,997 Value ($000) $3,010 Avg Close $26.51 Range $21.99 - $29.90
Q3 2023
Shares 80,584 Value ($000) $2,222 Avg Close $30.44 Range $27.26 - $32.98
Q2 2023
Shares 56,219 Value ($000) $1,690 Avg Close $34.99 Range $29.59 - $39.09
Q1 2023
Shares 17,399 Value ($000) $630 Avg Close $38.45 Range $34.33 - $42.09
Q4 2022
Shares 13,459 Value ($000) $480 Avg Close $34.75 Range $30.00 - $38.40